CHEK logo

PT Diastika Biotekindo Tbk Stock Price

IDX:CHEK Community·Rp581.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CHEK Share Price Performance

Rp179.00
7.00 (4.07%)
Rp179.00
7.00 (4.07%)
Price Rp179.00

CHEK Community Narratives

There are no narratives available yet.

Recent CHEK News & Updates

PT Diastika Biotekindo Tbk Key Details

Rp171.3b

Revenue

Rp103.5b

Cost of Revenue

Rp67.8b

Gross Profit

Rp45.9b

Other Expenses

Rp21.9b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
6.73
Gross Margin
39.58%
Net Profit Margin
12.78%
Debt/Equity Ratio
0.1%

PT Diastika Biotekindo Tbk Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with proven track record.

1 Risk
2 Rewards

About CHEK

Founded
1989
Employees
109
CEO
Franciscus Yoshua Raintjung
WebsiteView website
diastika.co.id

PT Diastika Biotekindo Tbk engages in the sale of disposable or consumable medical goods and diagnostic equipment. The company offers various products for detecting, diagnosing, and monitoring human disease. It also offers life science products that are processed from biological products. PT Diastika Biotekindo was founded in 1989 and is headquartered in Jakarta Timur, Jakarta Raya, Indonesia. PT Diastika Biotekindo Tbk is a subsidiary of PT Optel Investama Mulia.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indonesian Market Performance

  • 7 Days: 1.4%
  • 3 Months: 21.4%
  • 1 Year: 15.5%
  • Year to Date: 18.6%
The market is up 1.4% over the last week, with the Materials sector leading the way, up 3.2%. In the last year, the market has climbed 16%. As for the next few years, earnings are expected to grow by 7.2% per annum. Market details ›